| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |